✦ LIBER ✦

Weekly docetaxel and trastuzumab for her-2-overexpressing metastatic breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study

✍ Scribed by S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Phase II study of weekly docetaxel (Taxo

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Multicenter phase II trial of three-week

✍ T Tabei; M Kimura; M Sano; T Asaga; J Ando; H Fujii; N Yamamoto; M Kurosumi; K I 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

370 Primary treatment with weekly doceta

✍ J. Bines; A. Murad; S. Lago; B. Ferrari; J. Andrade; E. Abdo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Phase II Study of Weekly Docetaxel and C

✍ Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A. Rhoades; Kari Kendra; J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB